IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: Regulation by IFN-γ

Immunotherapy

Volumn 3, Issue 4 SUPPL., 2011, Pages 23-26

  Jeannin, Pascale ^a,b,c   Duluc, Dorothée ^a,b,d   Delneste, Yves ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

cancer; IL 6; immunosuppresion; LIF; macrophage

Indexed keywords

CANCER VACCINE; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; T CELL VACCINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; CELL DIFFERENTIATION; CELL FUNCTION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSION; INTERFERON-GAMMA; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MACROPHAGES; MONOCYTES; OVARIAN NEOPLASMS; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 79955577703     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.11.30     Document Type: Article

References (23)

1. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5(12), 953-964 (2005). (Pubitemid 41746764)
2. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23(11), 549-555 (2002). (Pubitemid 35223554)
3. Zou W: Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5(4), 263-274 (2005). (Pubitemid 40488632)
4. Nishikawa H, Sakaguchi S: Regulatory T cells in tumor immunity. Int. J. Cancer 127(4), 759-767 (2010).
5. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4(1), 71-78 (2004). (Pubitemid 38082155)
6. Mantovani A, Allavena P, Sica A: Tumour-associated macrophages as a prototypic type II polarized phagocyte population: role in tumour progression. Eur. J. Cancer 40(11), 1660-1667 (2004). (Pubitemid 38902900)
7. Condeelis J, Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2), 263-266 (2006). (Pubitemid 43121975)
8. Chomarat P, Banchereau J, Davoust J, Palucka AK: IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1(6), 510-514 (2000).
9. Allavena P, Piemonti L, Longoni D et al.: IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran. Adv. Exp. Med. Biol. 417, 323-327 (1997). (Pubitemid 27427763)
10. Gabrilovich D, Ishida T, Oyama T et al.: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92(11), 4150-4166 (1998). (Pubitemid 28544331)
11. Kryczek I, Zou L, Rodriguez P et al.: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203(4), 871-881 (2006).
12. Mantovani A, Sica A: Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22(2), 231-237 (2010).
13. Curiel TJ, Wei S, Dong H et al.: Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9(5), 562-567 (2003). (Pubitemid 36597102)
14. Hoves S, Krause SW, Schutz C et al.: Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J. Immunol. 177(4), 2691-2698 (2006). (Pubitemid 44201028)
15. Allavena P, Piemonti L, Longoni D et al.: IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28(1), 359-369 (1998). (Pubitemid 28048306)
16. Hagemann T, Wilson J, Burke F et al.: Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 176(8), 5023-5032 (2006).
17. Duluc D, Delneste Y, Tan F et al.: Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110(13), 4319-4330 (2007). (Pubitemid 351377797)
18. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008). (Pubitemid 351599757)
19. Biswas SK, Gangi L, Paul S et al.: A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kB and enhanced IRF-3/STAT1 activation). Blood 107(5), 2112-2122 (2006). (Pubitemid 43289397)
20. Metcalf D: The unsolved enigmas of leukemia inhibitory factor. Stem Cells 21(1), 5-14 (2003). (Pubitemid 36120360)
21. Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9(3), 162-174 (2009).
22. Duluc D, Corvaisier M, Blanchard S et al.: Interferon-g reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 125(2), 367-373 (2009).
23. Aharinejad S, Abraham D, Paulus P et al.: Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 62(18), 5317-5324 (2002). (Pubitemid 35024608)